SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC14D9C - Written communication relating to third party tender offer:
SEC Accession No. 0001193125-22-180256
Filing Date
2022-06-23
Accepted
2022-06-23 16:58:31
Documents
11

Document Format Files

Seq Description Document Type Size
1 SC14D9C d236905dsc14d9c.htm SC14D9C 17188
2 EX-99.1 d236905dex991.htm EX-99.1 7827
3 EX-99.2 d236905dex992.htm EX-99.2 20852
4 EX-99.3 d236905dex993.htm EX-99.3 6036
5 EX-99.4 d236905dex994.htm EX-99.4 6035
6 EX-99.5 d236905dex995.htm EX-99.5 8213
7 GRAPHIC g236905dsp011.jpg GRAPHIC 317069
8 GRAPHIC g236905dsp012.jpg GRAPHIC 172100
9 GRAPHIC g236905dsp013.jpg GRAPHIC 167443
10 GRAPHIC g236905page020.jpg GRAPHIC 60794
11 GRAPHIC g236905page022.jpg GRAPHIC 59277
  Complete submission text file 0001193125-22-180256.txt   1133027
Mailing Address 35 PARKWOOD DRIVE BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT
Business Address 35 PARKWOOD DRIVE BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT 44 1223 497400
F-star Therapeutics, Inc. (Filed by) CIK: 0001566373 (see all company filings)

IRS No.: 522386345 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC14D9C
SIC: 2834 Pharmaceutical Preparations

Mailing Address 35 PARKWOOD DRIVE BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT
Business Address 35 PARKWOOD DRIVE BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT 44 1223 497400
F-star Therapeutics, Inc. (Subject) CIK: 0001566373 (see all company filings)

IRS No.: 522386345 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC14D9C | Act: 34 | File No.: 005-89626 | Film No.: 221036147
SIC: 2834 Pharmaceutical Preparations